Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.

ENT providers can perform allergy testing and develop personalized treatment plans, which may include medications or immunotherapy to address specific triggers. For chronic sinusitis or severe sinus ...

The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...

Amgen and AstraZeneca said on Friday that their asthma drug Tezspire reduced nasal congestion and the size of nasal polyps in patients with a different but sometimes related inflammatory condition ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Expert says, that by recognising the connection between seasonal changes, allergies, and sinus health, individuals can take ...